Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00206414 Information provided by Baylor Breast Care Center

First Received: September 12, 2005 Last Updated: November 16, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2012
Primary Completion Date:	May 2006 (Final data collection date for primary outcome measure)

No publications provided by Baylor Breast Care Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S, Elledge R. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011 Oct;129(3):819-27. Epub 2011 Jul 27.